Research across Kidney Diseases
Related studies from across the Kidney Diseases family.
5 trials tracked for kidney transplant recipients: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 31 citations.
Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Envarsus XR was evaluated for its impact on Calcineurin Inhibitor-related Symptoms (CIRS). While there was no statistically significant mean change in the overall CIRS severity score (-2.977; -3.139, p=0.944) or in any of the five individual CIRS items (p=0.345), a statistically significant difference was observed in the number of subjects with moderately severe, severe, or very severe scores on any CIRS item (18 vs 28, p=0.010).
Mycophenolic acid was utilized in patients post-transplant to manage and monitor for biopsy-confirmed acute rejection based on Banff '97 criteria.
AI synthesis of 0 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Kidney Diseases family.